A Survey of Community Dermatologists Reveals the Unnecessary Impact of Trial-and-Error Behavior on the Psoriasis Biologic Treatment Paradigm

INTRODUCTION: In the USA, psoriasis affects approximately 3% of the population and costs more than $110 billion annually. The development of targeted biologics has revolutionized psoriasis management, but at an increasing cost. According to Joint AAD/NPF guidelines, an important need exists to ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Strober, Bruce, Pariser, David, Deren-Lewis, Ann, Dickerson, Tobin J., Lebwohl, Mark, Menter, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Practical Approach
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484423/
https://www.ncbi.nlm.nih.gov/pubmed/34275121
http://dx.doi.org/10.1007/s13555-021-00573-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484423/
https://www.ncbi.nlm.nih.gov/pubmed/34275121
http://dx.doi.org/10.1007/s13555-021-00573-1

Ejemplares similares